JP2021536260A5 - - Google Patents
Info
- Publication number
- JP2021536260A5 JP2021536260A5 JP2021512665A JP2021512665A JP2021536260A5 JP 2021536260 A5 JP2021536260 A5 JP 2021536260A5 JP 2021512665 A JP2021512665 A JP 2021512665A JP 2021512665 A JP2021512665 A JP 2021512665A JP 2021536260 A5 JP2021536260 A5 JP 2021536260A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- car
- cells
- binds
- blcl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024118790A JP7882904B2 (ja) | 2018-09-10 | 2024-07-24 | 抗原特異的ｃａｒ－ｔ細胞を拡大増殖する方法、それに関連する組成物及び使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862729089P | 2018-09-10 | 2018-09-10 | |
| US62/729,089 | 2018-09-10 | ||
| US201962896707P | 2019-09-06 | 2019-09-06 | |
| US62/896,707 | 2019-09-06 | ||
| PCT/US2019/050404 WO2020055862A1 (en) | 2018-09-10 | 2019-09-10 | Methods for expanding antigen-specific car-t cells, compositions and uses related thereto |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024118790A Division JP7882904B2 (ja) | 2018-09-10 | 2024-07-24 | 抗原特異的ｃａｒ－ｔ細胞を拡大増殖する方法、それに関連する組成物及び使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021536260A JP2021536260A (ja) | 2021-12-27 |
| JP2021536260A5 true JP2021536260A5 (enExample) | 2022-09-16 |
| JP7528059B2 JP7528059B2 (ja) | 2024-08-05 |
Family
ID=69778136
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021512665A Active JP7528059B2 (ja) | 2018-09-10 | 2019-09-10 | 抗原特異的ｃａｒ－ｔ細胞を拡大増殖する方法、それに関連する組成物及び使用 |
| JP2024118790A Active JP7882904B2 (ja) | 2018-09-10 | 2024-07-24 | 抗原特異的ｃａｒ－ｔ細胞を拡大増殖する方法、それに関連する組成物及び使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024118790A Active JP7882904B2 (ja) | 2018-09-10 | 2024-07-24 | 抗原特異的ｃａｒ－ｔ細胞を拡大増殖する方法、それに関連する組成物及び使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20210301255A1 (enExample) |
| EP (2) | EP4458419A3 (enExample) |
| JP (2) | JP7528059B2 (enExample) |
| KR (1) | KR102997522B1 (enExample) |
| CN (1) | CN112969470A (enExample) |
| AU (1) | AU2019338307B2 (enExample) |
| BR (1) | BR112021004465A2 (enExample) |
| CA (1) | CA3111796A1 (enExample) |
| ES (1) | ES3000183T3 (enExample) |
| IL (1) | IL281187A (enExample) |
| MX (1) | MX2021002702A (enExample) |
| SG (1) | SG11202101468XA (enExample) |
| WO (1) | WO2020055862A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2021002702A (es) * | 2018-09-10 | 2021-05-12 | Atara Biotherapeutics Inc | Metodos para expandir celulas t del receptor de antigeno quimerico especificas de antigenos, composiciones y usos relacionados con las mismas. |
| EP4578507A3 (en) | 2018-11-01 | 2025-11-12 | Gracell Biotechnologies (Shanghai) Co., Ltd. | Compositions and methods for t cell engineering |
| CN113226340A (zh) | 2018-11-26 | 2021-08-06 | 恩卡尔塔公司 | 同时扩增多种免疫细胞类型的方法、相关组合物及其在癌症免疫疗法中的用途 |
| CN118931967A (zh) * | 2018-12-07 | 2024-11-12 | 亘喜生物科技（上海）有限公司 | 用于免疫疗法的组合物和方法 |
| KR20210137085A (ko) | 2019-03-05 | 2021-11-17 | 엔카르타, 인크. | Cd19 유도된 키메라 항원 수용체 및 면역 요법에서 이의 용도 |
| EP3786178A1 (en) | 2019-08-30 | 2021-03-03 | Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft | Tcr constructs specific for ebv-derived antigens |
| CA3208273A1 (en) * | 2021-01-20 | 2022-07-28 | Coding Bio Limited | Methods for high throughput screening of chimeric antigen receptors |
| EP4381050A4 (en) * | 2021-08-06 | 2025-10-08 | Seattle Childrens Hospital D/B/A Seattle Childrens Res Institute | T CELL MANUFACTURING PROCESSES |
| WO2023159088A1 (en) * | 2022-02-15 | 2023-08-24 | Marker Therapeutics, Inc. | Compositions and methods for antigen-specific t cell expansion |
| WO2023230276A1 (en) * | 2022-05-27 | 2023-11-30 | Kite Pharma, Inc. | Compositions and methods for preparing engineered lymphocytes for cell therapy |
| WO2024013702A2 (en) * | 2022-07-15 | 2024-01-18 | Medimmune, Llc | Methods for expanding t cell populations |
| IL327180A (en) * | 2023-10-03 | 2026-05-01 | Atara Biotherapeutics Inc | Bispecific CD19/CD20-targeted chimeric receptors and their uses |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| US5019369A (en) | 1984-10-22 | 1991-05-28 | Vestar, Inc. | Method of targeting tumors in humans |
| US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| WO2003057171A2 (en) | 2002-01-03 | 2003-07-17 | The Trustees Of The University Of Pennsylvania | Activation and expansion of t-cells using an engineered multivalent signaling platform |
| WO2006056027A1 (en) | 2004-11-29 | 2006-06-01 | The Council Of The Queensland Institute Of Medical Research | Human cytomegalovirus immunotherapy |
| BR112014014591A8 (pt) | 2011-12-12 | 2017-07-04 | Baylor College Medicine | processo para a expansão in vitro de células t específicas de antígeno, produto de células t autólogas ou alogênicas expandidas, composição farmacêutica, e, método de tratamento de um paciente, e, usos de uma linhagem de células engenheirada, de células dendríticas pulsadas com misturas de antígeno-peptídeo, de t-apcs pulsadas com misturas de antígeno-peptídeo/peptídeo, e de misturas de antígeno-peptídeo com pbmcs |
| JP2015533366A (ja) | 2012-10-19 | 2015-11-24 | ザ・カウンシル・オヴ・ザ・クイーンズランド・インスティテュート・オヴ・メディカル・リサーチ | 改良されたヒトヘルペスウイルス免疫療法 |
| CN104462128B (zh) | 2013-09-22 | 2018-04-13 | 腾讯科技（深圳）有限公司 | 多媒体文件处理的方法、装置和终端设备 |
| WO2015154012A1 (en) * | 2014-04-03 | 2015-10-08 | Memorial Sloan-Kettering Cancer Center | Clonogenic natural killer (nk) cell populations and methods of producing and using such populations |
| EA201791806A1 (ru) * | 2015-02-10 | 2017-12-29 | Орегон Хелс Энд Сайенс Юниверсити | Способы и композиции, полезные при генерировании неканонических cd8+ т-клеточных ответов |
| WO2016154628A1 (en) * | 2015-03-26 | 2016-09-29 | Xiuli Wang | Bi-specific targeted chimeric antigen receptor t cells |
| AU2016291825B2 (en) * | 2015-07-16 | 2022-08-11 | Yeda Research And Development Co. Ltd. | Genetically modified anti-third party central memory T cells and use of same in immunotherapy |
| AU2017271136A1 (en) | 2016-05-23 | 2019-01-03 | The Council Of The Queensland Institute Of Medical Research | CMV epitopes |
| CN109475578A (zh) | 2016-05-25 | 2019-03-15 | 昆士兰医学研究所理事会 | 使用同种异体t细胞治疗自身免疫疾病的方法 |
| BR112019004102A2 (pt) | 2016-09-09 | 2019-05-28 | Atara Biotherapeutics, Inc. | imunoterapia para poliomavírus |
| JP7002769B2 (ja) * | 2016-09-16 | 2022-02-04 | ベイラー カレッジ オブ メディスン | ウイルス特異的ｔ細胞の活性化および拡大のためのプラットフォーム |
| WO2018075813A1 (en) * | 2016-10-19 | 2018-04-26 | City Of Hope | Use of endogenous viral vaccine in chimeric antigen receptor t cell therapy |
| CN111212663A (zh) | 2017-07-07 | 2020-05-29 | H·李·莫菲特癌症中心研究所公司 | 具有突变的cd28共刺激性结构域的嵌合抗原受体 |
| IL326873A (en) | 2017-12-29 | 2026-04-01 | Memorial Sloan Kettering Cancer Center | Enhanced chimeric antigen receptors and uses thereof |
| MX2021002702A (es) * | 2018-09-10 | 2021-05-12 | Atara Biotherapeutics Inc | Metodos para expandir celulas t del receptor de antigeno quimerico especificas de antigenos, composiciones y usos relacionados con las mismas. |
-
2019
- 2019-09-10 MX MX2021002702A patent/MX2021002702A/es unknown
- 2019-09-10 CA CA3111796A patent/CA3111796A1/en active Pending
- 2019-09-10 AU AU2019338307A patent/AU2019338307B2/en active Active
- 2019-09-10 CN CN201980073697.6A patent/CN112969470A/zh active Pending
- 2019-09-10 ES ES19860431T patent/ES3000183T3/es active Active
- 2019-09-10 US US17/274,673 patent/US20210301255A1/en not_active Abandoned
- 2019-09-10 KR KR1020217010391A patent/KR102997522B1/ko active Active
- 2019-09-10 EP EP24197954.1A patent/EP4458419A3/en active Pending
- 2019-09-10 WO PCT/US2019/050404 patent/WO2020055862A1/en not_active Ceased
- 2019-09-10 JP JP2021512665A patent/JP7528059B2/ja active Active
- 2019-09-10 BR BR112021004465-5A patent/BR112021004465A2/pt unknown
- 2019-09-10 EP EP19860431.6A patent/EP3849571B1/en active Active
- 2019-09-10 SG SG11202101468XA patent/SG11202101468XA/en unknown
-
2021
- 2021-03-02 IL IL281187A patent/IL281187A/en unknown
-
2024
- 2024-07-24 JP JP2024118790A patent/JP7882904B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Maldini et al. | CAR T cells for infection, autoimmunity and allotransplantation | |
| KR102768263B1 (ko) | Nk 세포 형질도입 방법 | |
| Tey et al. | Inducible caspase 9 suicide gene to improve the safety of allodepleted T cells after haploidentical stem cell transplantation | |
| Ptáčková et al. | A new approach to CAR T-cell gene engineering and cultivation using piggyBac transposon in the presence of IL-4, IL-7 and IL-21 | |
| CN112204133B (zh) | Car nk细胞 | |
| EP3849571B1 (en) | Methods for expanding antigen-specific car-t cells, compositions and uses related thereto | |
| AU2017330379B2 (en) | Generation and use in adoptive immunotherapy of stem cell-like memory T cells | |
| CN111566201A (zh) | 使用用于表达嵌合抗原受体(car)或转基因t细胞受体(tcr)的病毒载体转导细胞的方法 | |
| US9670459B2 (en) | Production method for cell populations | |
| Xu et al. | Toward precision manufacturing of immunogene T-cell therapies | |
| MXPA04009287A (es) | Proceso para producir linfocito citotoxico. | |
| JP2025066794A (ja) | 遺伝子改変自己ｔ細胞を製造するためのプロセス | |
| TW202430629A (zh) | 利用慢病毒載體轉染之新穎大規模car-t免疫細胞製造方法 | |
| JPH11509411A (ja) | 樹状細胞のインビトロ増殖のための方法、三次元マトリクス中にエントラップされたその細胞を含む組成物、および免疫のための使用 | |
| Wang et al. | Alloreactive-free CAR-VST therapy: a step forward in long-term tumor control in viral context | |
| Li et al. | Preclinical development and clinical-scale manufacturing of HIV Gag-specific, lentivirusmodified CD4 T cells for HIV functional cure | |
| WO2022040631A1 (en) | Methods for isolating cd8+ selected t cells | |
| Zhou et al. | CD123 redirected multiple virus-specific T cells for acute myeloid leukemia | |
| Jurgens et al. | Transduction of primary lymphocytes with Epstein-Barr virus (EBV) latent membrane protein-specific T-cell receptor induces lysis of virus-infected cells: a novel strategy for the treatment of Hodgkin's disease and nasopharyngeal carcinoma | |
| US20250101467A1 (en) | Preparation technique for universal car-t cell, and use of universal car-t cell thereof | |
| Muñoz et al. | Ex vivo expansion and lentiviral transduction of Macaca nemestrina CD4+ T cells | |
| RU2021109354A (ru) | Способы экспандирования антигенспецифических car-t-клеток, композиции и применения, связанные с ними | |
| Fesnak et al. | Immunotherapy with Autologous Cells | |
| Savoldo et al. | therapy: a step forward in long-term tumor control | |
| Lara de León | Development of Epstein-Barr Virus-Specific T cells expressing anti-CD19 Chimeric Antigen Receptor for cancer immunotherapy |